TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 88 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 260,000 | $5,260,000 | 2.44% |
| Avoro Capital Advisors LLC | 160,697 | $3,234,000 | 1.24% |
| Private Capital Advisors, Inc. | 83,820 | $1,696,000 | 0.62% |
| Monashee Investment Management LLC | 25,000 | $506,000 | 0.32% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $1,922,000 | 0.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 226,064 | $4,573,000 | 0.15% |
| Spark Investment Management LLC | 36,700 | $745,000 | 0.10% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,121 | $589,000 | 0.04% |
| A.R.T. Advisors, LLC | 15,480 | $313,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 1,200 | $31,000 | 0.00% |